rs431905504
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001044.5(SLC6A3):c.1269+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000359 in 1,393,474 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001044.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A3 | NM_001044.5 | c.1269+1G>A | splice_donor_variant, intron_variant | ENST00000270349.12 | NP_001035.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A3 | ENST00000270349.12 | c.1269+1G>A | splice_donor_variant, intron_variant | 1 | NM_001044.5 | ENSP00000270349.9 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000639 AC: 1AN: 156398Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 82436
GnomAD4 exome AF: 0.00000359 AC: 5AN: 1393474Hom.: 0 Cov.: 31 AF XY: 0.00000291 AC XY: 2AN XY: 687632
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Classic dopamine transporter deficiency syndrome Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing;provider interpretation | Geisinger Autism and Developmental Medicine Institute, Geisinger Health System | Dec 07, 2017 | This is a 7 year old female with extrapyramidal movement disorder, global developmental delay, hip dysplasia, failure to thrive, febrile seizures, scoliosis, spina bifida occulta, and quadriplegia. Cognitive abilities are uncertain. Brain MRI showed immature myelination. She is homozygous for this variant and her presentation is consistent with dopamine transporter deficiency syndrome. This variant has been reported previously in 2 siblings with DAT deficiency (Puffenberger, 2012). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 2012 | - - |
Parkinsonism-dystonia, infantile Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 04, 2022 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 29685). Disruption of this splice site has been observed in individuals with infantile parkinsonism-dystonia (PMID: 22279524, 24613933). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change affects a donor splice site in intron 9 of the SLC6A3 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SLC6A3 are known to be pathogenic (PMID: 21112253). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 18, 2019 | Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 24613933, 22279524, 31028937) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at